Russell Investments Group Ltd. boosted its holdings in Addus HomeCare Corporation (NASDAQ:ADUS - Free Report) by 39.2% during the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 50,790 shares of the company's stock after acquiring an additional 14,302 shares during the quarter. Russell Investments Group Ltd. owned 0.28% of Addus HomeCare worth $5,023,000 at the end of the most recent reporting period.
Other institutional investors have also added to or reduced their stakes in the company. Natixis increased its stake in Addus HomeCare by 111.9% in the 4th quarter. Natixis now owns 250 shares of the company's stock worth $31,000 after acquiring an additional 132 shares during the last quarter. Bailard Inc. bought a new position in Addus HomeCare in the 1st quarter worth about $208,000. Heritage Family Offices LLP increased its stake in Addus HomeCare by 6.3% in the 1st quarter. Heritage Family Offices LLP now owns 2,417 shares of the company's stock worth $239,000 after acquiring an additional 143 shares during the last quarter. Private Advisor Group LLC boosted its holdings in shares of Addus HomeCare by 52.4% in the 1st quarter. Private Advisor Group LLC now owns 2,546 shares of the company's stock worth $252,000 after purchasing an additional 875 shares in the last quarter. Finally, Hohimer Wealth Management LLC boosted its holdings in shares of Addus HomeCare by 6.3% in the 1st quarter. Hohimer Wealth Management LLC now owns 2,561 shares of the company's stock worth $253,000 after purchasing an additional 152 shares in the last quarter. 95.35% of the stock is currently owned by institutional investors.
Insider Buying and Selling
In related news, Director Veronica Hill-Milbourne sold 1,571 shares of the firm's stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $114.93, for a total transaction of $180,555.03. Following the completion of the transaction, the director owned 5,067 shares of the company's stock, valued at $582,350.31. This trade represents a 23.67% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, CEO R Dirk Allison sold 25,000 shares of the firm's stock in a transaction that occurred on Wednesday, August 20th. The shares were sold at an average price of $114.95, for a total value of $2,873,750.00. Following the transaction, the chief executive officer directly owned 166,461 shares of the company's stock, valued at approximately $19,134,691.95. This trade represents a 13.06% decrease in their position. The disclosure for this sale can be found here. 4.50% of the stock is owned by company insiders.
Addus HomeCare Stock Down 2.4%
Shares of NASDAQ:ADUS traded down $2.78 during trading on Tuesday, hitting $113.87. The stock had a trading volume of 41,219 shares, compared to its average volume of 190,608. Addus HomeCare Corporation has a 12 month low of $88.96 and a 12 month high of $136.72. The company has a market capitalization of $2.10 billion, a PE ratio of 25.24, a PEG ratio of 1.80 and a beta of 0.80. The firm's fifty day moving average is $112.02 and its 200 day moving average is $106.90. The company has a quick ratio of 1.74, a current ratio of 1.74 and a debt-to-equity ratio of 0.17.
Addus HomeCare (NASDAQ:ADUS - Get Free Report) last announced its earnings results on Monday, August 4th. The company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.45 by $0.04. Addus HomeCare had a return on equity of 9.39% and a net margin of 6.51%.The firm had revenue of $349.44 million during the quarter, compared to analyst estimates of $345.71 million. During the same quarter in the prior year, the company earned $1.35 EPS. The business's revenue was up 21.8% compared to the same quarter last year. Analysts anticipate that Addus HomeCare Corporation will post 4.59 EPS for the current fiscal year.
Wall Street Analysts Forecast Growth
A number of equities analysts have recently issued reports on ADUS shares. Macquarie reiterated an "outperform" rating and issued a $133.00 price objective on shares of Addus HomeCare in a report on Tuesday, June 10th. JMP Securities reiterated a "market outperform" rating and issued a $150.00 price objective on shares of Addus HomeCare in a report on Wednesday, July 16th. TD Cowen upped their price objective on Addus HomeCare from $135.00 to $139.00 and gave the stock a "buy" rating in a report on Wednesday, August 6th. Wall Street Zen upgraded Addus HomeCare from a "hold" rating to a "buy" rating in a report on Sunday, June 29th. Finally, Royal Bank Of Canada increased their target price on Addus HomeCare from $133.00 to $134.00 and gave the company an "outperform" rating in a report on Friday. Two equities research analysts have rated the stock with a Strong Buy rating, six have assigned a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of "Buy" and a consensus target price of $138.38.
Get Our Latest Stock Report on ADUS
About Addus HomeCare
(
Free Report)
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.
Featured Articles

Before you consider Addus HomeCare, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Addus HomeCare wasn't on the list.
While Addus HomeCare currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.